Partnering For Precision In Small Molecules

Syngene International is a globally recognized Contract Research, Development, and Manufacturing Organization (CRDMO), delivering integrated solutions across the entire drug discovery, development, and manufacturing continuum. With over three decades of experience, we partner with pharmaceutical and biotechnology companies to address complex scientific and manufacturing challenges with precision and scale.

We provide integrated capabilities across small and large molecules, HPAPIs, oligonucleotides, peptides, and ADCs, enabling a seamless transition from discovery through development to commercialization. As a one-stop partner, we combine scientific depth with operational excellence to support a diverse global client base.

Our small molecule drug substance development and manufacturing services are supported by a multidisciplinary team and world-class infrastructure, enabling efficient execution across a broad range of modalities, including oligonucleotides, peptides, polymers, and HPAPIs.